Brian Kennedy
Direttore Tecnico/Scientifico/R&S presso Affirmativhealth
Profilo
Brian Kennedy is currently the Director-Centre for Healthy Ageing at Yong Loo Lin School of Medicine and the Scientific Director at Affirmativhealth.
He was previously the President & Chief Executive Officer at Buck Institute for Research on Aging from 2010 to 2016.
He also served as Co-Chairman at Mount TAM Biotechnologies, Inc. and Director at L-Nutra, Inc. Dr. Kennedy holds a doctorate degree from Massachusetts Institute of Technology.
Posizioni attive di Brian Kennedy
Società | Posizione | Inizio |
---|---|---|
Yong Loo Lin School of Medicine | Corporate Officer/Principal | - |
Affirmativhealth
Affirmativhealth Medical/Nursing ServicesHealth Services Affirmativhealth engages in treating Alzheimer's disease. The private company is based in Bellingham, WA. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Brian Kennedy
Società | Posizione | Fine |
---|---|---|
Buck Institute for Research on Aging
Buck Institute for Research on Aging Miscellaneous Commercial ServicesCommercial Services Buck Institute for Research on Aging operates independent research institute for connection between aging and chronic disease. The company is headquartered in Novato, CA. | Amministratore Delegato | 01/12/2016 |
L-Nutra, Inc.
L-Nutra, Inc. Pharmaceuticals: OtherHealth Technology L-Nutra, Inc. develops nutri-technologies that mimic the effects of fasting, to enhance the body?s natural ability to rejuvenate itself and promote longevity. The company was founded by Valter Longo and is headquartered in Los Angeles, CA. | Direttore/Membro del Consiglio | - |
Mount TAM Biotechnologies, Inc.
Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Presidente | - |
Formazione di Brian Kennedy
Massachusetts Institute of Technology | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Mount TAM Biotechnologies, Inc.
Mount TAM Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Mount TAM Biotechnologies, Inc. is a biopharmaceutical company, which engages in the development of therapeutic products for targeting systemic lupus erythematosus ("SLE"). It also focuses in the discovery and development of novel mTOR inhibitors, with specific emphasis on developing compounds with unique mTORC1:mTORC2 inhibitory profiles. The company was founded by Chester P. Aldridge in November 2011 and is headquartered in Burlington, VT. | Health Technology |
Buck Institute for Research on Aging
Buck Institute for Research on Aging Miscellaneous Commercial ServicesCommercial Services Buck Institute for Research on Aging operates independent research institute for connection between aging and chronic disease. The company is headquartered in Novato, CA. | Commercial Services |
Affirmativhealth
Affirmativhealth Medical/Nursing ServicesHealth Services Affirmativhealth engages in treating Alzheimer's disease. The private company is based in Bellingham, WA. | Health Services |
L-Nutra, Inc.
L-Nutra, Inc. Pharmaceuticals: OtherHealth Technology L-Nutra, Inc. develops nutri-technologies that mimic the effects of fasting, to enhance the body?s natural ability to rejuvenate itself and promote longevity. The company was founded by Valter Longo and is headquartered in Los Angeles, CA. | Health Technology |
- Borsa valori
- Insiders
- Brian Kennedy